Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Roza Badr-Eslam"'
Autor:
Lore Schrutka, Benjamin Seirer, René Rettl, Theresa-Marie Dachs, Christina Binder, Franz Duca, Daniel Dalos, Roza Badr-Eslam, Johannes Kastner, Christian Hengstenberg, Florian Frommlet, Diana Bonderman
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveWe sought to develop a clinical model to identify heart failure patients with preserved ejection fraction (HFpEF) at highest risk for acute HF events or death.Methods and resultsBetween 2010 and 2019, 422 patients with HFpEF were followed. A
Externí odkaz:
https://doaj.org/article/47204b460ed143a29da185abfc63a2ae
Autor:
Otto Pichlhöfer, Manfred Maier, Roza Badr-Eslam, Robin Ristl, Magdalena Zebrowska, Irene M Lang
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176257 (2017)
BACKGROUND:Cardiovascular disease is the main cause of death in Austria. However, no systematic information exists regarding characteristics and treatments of contemporary patients with stable coronary artery disease (CAD) in Austria. We assembled tw
Externí odkaz:
https://doaj.org/article/4fff11d0e09b460489a31b885fd24479
Autor:
Christina Kronberger, Robin Willixhofer, Roya Anahita Mousavi, Mariusz Tadeusz Grzeda, Brigitte Litschauer, Christoph Krall, Roza Badr Eslam
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/e7b46a19e1ee4620a7397d86cd0067fe
Autor:
René Rettl, Franz Duca, Christina Binder, Theresa-Marie Dachs, Bernhard Cherouny, Luciana Camuz Ligios, Christopher Mann, Lore Schrutka, Daniel Dalos, Silvia Charwat-Resl, Roza Badr Eslam, Johannes Kastner, Diana Bonderman
Publikováno v:
Amyloid. 30:127-137
The impact of tafamidis on myocardial strain in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) have been barely investigated. We aimed to determine tafamidis-induced changes using serial speckle tracking echocardiography and to identify
Autor:
Theresa Marie Dachs, Franz Duca, René Rettl, Christina Binder-Rodriguez, Daniel Dalos, Luciana Camuz Ligios, Andreas Kammerlander, Ekkehard Grünig, Ingrid Pretsch, Regina Steringer-Mascherbauer, Klemens Ablasser, Manfred Wargenau, Julia Mascherbauer, Irene M Lang, Christian Hengstenberg, Roza Badr-Eslam, Johannes Kastner, Diana Bonderman
Publikováno v:
European Heart Journal. 43:3402-3413
Aims The presence of pulmonary hypertension (PH) severely aggravates the clinical course of heart failure with preserved ejection fraction (HFpEF). To date, neither established heart failure therapies nor pulmonary vasodilators proved beneficial. Thi
Autor:
René Rettl, Tim Wollenweber, Franz Duca, Christina Binder, Bernhard Cherouny, Theresa-Marie Dachs, Camuz Ligios Luciana, Lore Schrutka, Daniel Dalos, Dietrich Beitzke, Christian Loewe, Roza Badr Eslam, Johannes Kastner, Marcus Hacker, Diana Bonderman
Publikováno v:
European Heart Journal - Cardiovascular Imaging.
Aims Tafamidis treatment positively affects left ventricular (LV) structure and function and improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). We aimed to investigate the relationship between treatment response and ca
Publikováno v:
HeilberufeScience. 13:23-34
Zusammenfassung Hintergrund Menschen nach akutem Koronarsyndrom weisen weiterhin ein hohes kardiovaskuläres Risiko auf. Eine pflegerische Intervention zur Verbesserung der Adhärenz von Betroffenen hinsichtlich der empfohlenen Präventionsmaßnahmen
Autor:
Franz DUCA, Rene RETTL, Christina BINDER, Fabian DUSIK, Lore SCHRUTKA, Daniel DALOS, Begüm ÖZTÜRK, Christophe D. CAPELLE, Hong QIN, Theresa M. DACHS, Luciana CAMUZ LIGIOS, Hermine AGIS, Renate KAIN, Christian HENGSTENBERG, Roza BADR-ESLAM, Johannes KASTNER, Diana BONDERMAN
Publikováno v:
Panminerva Medica.
Autor:
Robin Willixhofer, René Rettl, Christina Kronberger, Franz Duca, Christina Binder, Andreas Kammerlander, Johannes Kastner, Jutta Bergler-Klein, Roza Badr Eslam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b635835206605021e4f0656fa3706328
https://doi.org/10.2139/ssrn.4359064
https://doi.org/10.2139/ssrn.4359064
Autor:
Roza Badr Eslam, Begüm Öztürk, René Rettl, Christophe Denis Josef Capelle, Hong Qin, Christina Binder, Theresa-Marie Dachs, Luciana Camuz Ligios, Franz Duca, Daniel Dalos, Lore Schrutka, Farideh Alasti, Johannes Kastner, Greisa Vila, Diana Bonderman
Publikováno v:
Circulation. Heart failure. 15(7)
Background: In patients with transthyretin amyloid cardiomyopathy, tafamidis was shown to slow the decline in 6-minute walking distance as compared with placebo. We aimed to define the impact of tafamidis and optimal background treatment on functiona